Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7377 p656
26 November 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Greater HIV prevention needed to slow epidemic

HIV prevention and treatment efforts need to be stepped up worldwide

HIV prevention and treatment efforts need to be stepped up worldwide

HIV infection rates are decreasing in some countries but the number of people living with HIV worldwide continues to rise, according to a report published by the Joint United Nations Programme on HIV/AIDS and the World Health Organization.

Kenya, Zimbabwe and some countries in the Caribbean region all show declines in HIV prevalence over the past few years, says the report. Recent developments in the Caribbean, such as increased condom use among workers in the sex industry and expansion of voluntary HIV testing and counselling, give cause for “guarded optimism”, says the report. However, there were over five million new infections in 2005 and the number of people living with HIV worldwide has reached 40.3 million. The largest increases in HIV infection have occurred in Eastern Europe and Central and East Asia, however, sub-Saharan Africa continues to be the most affected region, with 64 per cent of new infections occurring there. The number of people receiving HIV antiretroviral therapy in low and middle income countries has tripled since the end of 2001, reveals the report. “Yet, at best, one in 10 Africans and one in seven Asians in need of antiretroviral treatment were receiving it in mid-2005,” it says.

In the UK, new diagnoses of HIV have doubled since 2000. The report states several reasons for this, including increased testing and a steep rise in the number of heterosexually acquired HIV infections, 80 per cent of which were contracted in high-prevalence countries. Women are especially affected, says the report, and sex between men still accounts for about a quarter of new diagnoses in the UK, it adds.

The report says that greater HIV prevention efforts are needed to slow the worldwide epidemic and calls for simultaneous acceleration of treatment and prevention efforts with the ultimate goal of universal access to preventive measures, treatment and care.

The report is published ahead of World AIDS Day, which will take place on 1 December.

Back to Top


©The Pharmaceutical Journal